 |
|
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah
Clin Mol Hepatol. 2022;28(3):565-574. Published online 2022 May 19 DOI: https://doi.org/10.3350/cmh.2022.0096
|
|
Citations to this article as recorded by
 Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
Hassam Ali, Muhammad Shahzil, Vishali Moond, Maria Shahzad, Abhay Thandavaram, Alina Sehar, Haniya Waseem, Taha Siddiqui, Dushyant Singh Dahiya, Pratik Patel, Hans Tillmann
Journal of Personalized Medicine.2024; 14(1): 61. CrossRef Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim
Metabolism.2024; 152: 155789. CrossRef Dietary Niacin Intake and Mortality Among Individuals With Nonalcoholic Fatty Liver Disease
Jie Pan, Yujia Zhou, Nengzhi Pang, Lili Yang
JAMA Network Open.2024; 7(2): e2354277. CrossRef Metabolic disorders in prediabetes: From mechanisms to therapeutic management
Wen-Xin Ping, Shan Hu, Jing-Qian Su, Song-Ying Ouyang
World Journal of Diabetes.2024; 15(3): 361. CrossRef Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
Sang Yi Moon, Yang Hyun Baek, Se Young Jang, Dae Won Jun, Ki Tae Yoon, Young Youn Cho, Hoon Gil Jo, Ae Jeong Jo
Gut and Liver.2024; 18(2): 283. CrossRef Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
Limin Cao, Yu An, Huiyuan Liu, Jinguo Jiang, Wenqi Liu, Yuhan Zhou, Mengyuan Shi, Wei Dai, Yanling Lv, Yuhong Zhao, Yanhui Lu, Liangkai Chen, Yang Xia
BMC Medicine.2024;[Epub] CrossRef Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Nicholas W.S. Chew, Xin Hui Pan, Bryan Chong, Chanchal Chandramouli, Mark Muthiah, Carolyn S.P. Lam
Diabetes Research and Clinical Practice.2024; : 111652. CrossRef Reply
Laurens A. van Kleef, Milan J. Sonneveld, Robert J. de Knegt
Hepatology.2023; 77(2): E30. CrossRef Letter to the editor: Screening for fatty liver disease and fibrosis in the elderly population: A call for action
Jie Li, Mindie H. Nguyen
Hepatology.2023; 77(2): E28. CrossRef The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals
Kai En Chan, Cheng Han Ng, Clarissa Elysia Fu, Jingxuan Quek, Gwyneth Kong, Yi Jie Goh, Rebecca Wenling Zeng, Michael Tseng, Manik Aggarwal, Benjamin Nah, Douglas Chee, Zhen Yu Wong, Sitong Zhang, Jiong-Wei Wang, Nicholas W.S. Chew, Yock Young Dan, Mohamm
Clinical Gastroenterology and Hepatology.2023; 21(10): 2560. CrossRef Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, Jieling Xiao, Jie Ning Yong, Bryan Tan, Nicholas Syn, Jiong-Wei Wang, Nilofer Sayed, Eunice Tan, Nicholas WS Chew, Yock Young Dan, Mo
Annals of Hepatology.2023; 28(1): 100762. CrossRef Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis
Jieling Xiao, Cheng Han Ng, Kai En Chan, Clarissa Fu, Phoebe Tay, Jie Ning Yong, Wen Hui Lim, Darren Jun Hao Tan, Nicholas Syn, Zhen Yu Wong, Michael Tseng, Nicholas Chew, Daniel Q. Huang, Yock Yong Dan, Vincent Wai-Sun Wong, Rohit Loomba, Mohammad S. Sid
Journal of Clinical and Experimental Hepatology.2023; 13(4): 656. CrossRef Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long‐term mortality in acute myocardial infarction
YipHan Chin, Jieyu Lim, Gwyneth Kong, Cheng Han Ng, Rachel Goh, Mark Muthiah, Anurag Mehta, Bryan Chong, Chaoxing Lin, Kai En Chan, William Kong, Kian Keong Poh, Roger Foo, Ping Chai, Tiong‐Cheng Yeo, Adrian F. Low, Chi Hang Lee, Huay Cheem Tan, Mark Yan‐
Diabetes, Obesity and Metabolism.2023; 25(4): 1032. CrossRef Metabolomics analysis of the serum metabolic signature of nonalcoholic fatty liver disease combined with prediabetes model rats after the intervention of Lycium barbarum polysaccharides combined with aerobic activity
Yanna Fan, Mengwei Zhang, Jiamin Ma, Yannan Zhang, Jianjun Yang
Biomedical Chromatography.2023;[Epub] CrossRef Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
Ho Soo Chun, Minjong Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Ji‐Hye Kim, Seung Up Kim
Liver International.2023; 43(3): 608. CrossRef Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee
European Journal of Gastroenterology & Hepatology.2023; 35(4): 431. CrossRef Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clinical and Molecular Hepatology.2023; 29(1): 185. CrossRef A two‐decade population‐based study on the effect of hypertension in the general population with obesity in the United States
Gwyneth Kong, Yip H. Chin, Jieyu Lim, Cheng H. Ng, Shankar Kannan, Bryan Chong, Chaoxing Lin, Kai E. Chan, Vickram V. Anand, Ethan C. Z. Lee, Shaun Loong, Zhen Y. Wong, Chin M. Khoo, Mark Muthiah, Roger Foo, Georgios K. Dimitriadis, Gemma A. Figtree, Yibi
Obesity.2023; 31(3): 832. CrossRef The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019
Bryan Chong, Gwyneth Kong, Kannan Shankar, H.S. Jocelyn Chew, Chaoxing Lin, Rachel Goh, Yip Han Chin, Darren Jun Hao Tan, Kai En Chan, Wen Hui Lim, Nicholas Syn, Siew Pang Chan, Jiong-Wei Wang, Chin Meng Khoo, Georgios K. Dimitriadis, Karn Wijarnpreecha,
Metabolism.2023; 141: 155402. CrossRef Racial/ethnic and gender disparity in the severity of NAFLD among people with diabetes or prediabetes
Magda Shaheen, Katrina M. Schrode, Marielle Tedlos, Deyu Pan, Sonia M. Najjar, Theodore C. Friedman
Frontiers in Physiology.2023;[Epub] CrossRef The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
Hyunwoo Oh, Won Sohn, Yong Kyun Cho
Clinical and Molecular Hepatology.2023; 29(Suppl): S261. CrossRef Mortality, Cardiovascular, and Medication Outcomes in Patients With Myocardial Infarction and Underweight in a Meta-Analysis of 6.3 Million Patients
Chaoxing Lin, Wan Hsien Loke, Bing Han Ng, Yip Han Chin, Bryan Chong, Rachel Sze Jen Goh, Gwyneth Kong, Christen En Ya Ong, Kai En Chan, Clarissa Fu, Tasha Idnani, Mark D. Muthiah, Chin Meng Khoo, Roger Foo, Poay Huan Loh, Mark Y. Chan, Adrian Brown, Geor
The American Journal of Cardiology.2023; 196: 1. CrossRef Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study
Karen D. Corbin, Anastassios G. Pittas, Cyrus Desouza, Kristine K. Grdinovac, Karl-Heinz Herzig, Sangeeta R. Kashyap, Sun H. Kim, Jason Nelson, Neda Rasouli, Ellen M. Vickery, William C. Knowler, Richard E. Pratley
Journal of Diabetes and its Complications.2023; 37(6): 108475. CrossRef General Public’s knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population
Vickram Vijay Anand, Rachel Sze Jen Goh, Benjamin Nah, Sky Wei Chee Koh, Jieyu Lim, Nicholas W. S. Neo, Jocelyn Chew, Yuan Ying Lee, Yip Han Chin, Bryan Chong, Gwyneth Kong, Bryan Tan, Zhiwen Low, Chin Meng Khoo, Lay Hoon Goh, Poay Huan Loh, Ping Chai, Ma
Frontiers in Medicine.2023;[Epub] CrossRef Socioeconomic deprivation and prognostic outcomes in acute coronary syndrome: A meta-analysis using multidimensional socioeconomic status indices
Vickram Vijay Anand, Ethan Lee Cheng Zhe, Yip Han Chin, Rachel Sze Jen Goh, Chaoxing Lin, Martin Tze Wah Kueh, Bryan Chong, Gwyneth Kong, Phoebe Wen Lin Tay, Mayank Dalakoti, Mark Muthiah, Georgios K. Dimitriadis, Jiong-Wei Wang, Anurag Mehta, Roger Foo,
International Journal of Cardiology.2023; 383: 140. CrossRef Performance Analysis and Assessment of Type 2 Diabetes Screening Scores in Patients with Non-Alcoholic Fatty Liver Disease
Norma Latif Fitriyani, Muhammad Syafrudin, Siti Maghfirotul Ulyah, Ganjar Alfian, Syifa Latif Qolbiyani, Chuan-Kai Yang, Jongtae Rhee, Muhammad Anshari
Mathematics.2023; 11(10): 2266. CrossRef Epicardial Adipose Tissue Assessed by Computed Tomography and Echocardiography Are Associated With Adverse Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Bryan Chong, Jayanth Jayabaskaran, Jitesh Ruban, Rachel Goh, Yip Han Chin, Gwyneth Kong, Cheng Han Ng, Chaoxing Lin, Shaun Loong, Mark D. Muthiah, Chin Meng Khoo, Ezman Shariff, Mark Y. Chan, Fannie Lajeunesse-Trempe, Andre Tchernof, Parag Chevli, Anurag
Circulation: Cardiovascular Imaging.2023;[Epub] CrossRef Editorial: The heart of NAFLD
Nicholas W. S. Chew, Shankar Kannan, Bryan Chong, Yiphan Chin, Mark Muthiah
Frontiers in Medicine.2023;[Epub] CrossRef The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
Anand V. Kulkarni, Shiv Kumar Sarin
Therapeutic Advances in Endocrinology and Metabolism.2023; 14: 204201882311783. CrossRef New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trials
Tanawan Kongmalai, Varalak Srinonprasert, Thunyarat Anothaisintawee, Pinkawas Kongmalai, Gareth McKay, John Attia, Ammarin Thakkinstian
Frontiers in Endocrinology.2023;[Epub] CrossRef Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States
Pegah Golabi, James M. Paik, Ameeta Kumar, Reem Al Shabeeb, Kathrine E. Eberly, Kenneth Cusi, Nagashree GunduRao, Zobair M. Younossi
Metabolism.2023; 146: 155642. CrossRef Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation
Sonia Samuel, Ahmad Abulawi, Raza Malik
Gastroenterology Insights.2023; 14(3): 249. CrossRef Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
Elina En Li Cho, Chong Zhe Ang, Jingxuan Quek, Clarissa Elysia Fu, Lincoln Kai En Lim, Zane En Qi Heng, Darren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, Rebecca Zeng, Douglas Chee, Benjamin Nah, Cosmas Rinaldi Adithya Lesmana, Aung Hlaing Bwa, Khin Maung W
Gut.2023; 72(11): 2138. CrossRef Relationship of cardiac remodeling and perfusion alteration with hepatic lipid metabolism in a prediabetic high fat high sucrose diet female rat model
A. Jouenne, K. Hamici, I. Varlet, J. Sourdon, P. Daudé, C. Lan, F. Kober, J.F. Landrier, M. Bernard, M. Desrois
Biochemical and Biophysical Research Communications.2023; 682: 207. CrossRef Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study
Beom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem K. Oz, Ayse Erden, Emily Truong, Ju Dong Yang, Mazen Noureddin, Alina M. Allen, Rohit Loomba, Veeral Ajmera
Hepatology.2023; 78(6): 1858. CrossRef Association between nonalcoholic fatty liver disease and type 2 diabetes: A bidirectional two-sample mendelian randomization study
Xuetong Ni, Chao Tong, Aheyeerke Halengbieke, Tengrui Cao, Jianmin Tang, Lixin Tao, Deqiang Zheng, Yumei Han, Qiang Li, Xinghua Yang
Diabetes Research and Clinical Practice.2023; 206: 110993. CrossRef Defining an approach for therapeutic strategies in metabolic dysfunction–associated steatotic liver disease after liver transplantation
Mohammad Shadab Siddiqui, Mark Muthiah, Sanjaya K. Satapathy, Kavish R. Patidar, Mamatha Bhat, Danielle Brandman, Kymberly D. Watt, Mary Rinella
Hepatology.2023;[Epub] CrossRef Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
Cheng Han Ng, Zhen Yu Wong, Nicholas W. S. Chew, Kai En Chan, Jieling Xiao, Nilofer Sayed, Wen Hui Lim, Darren Jun Hao Tan, Ryan Wai Keong Loke, Phoebe Wen Lin Tay, Jie Ning Yong, Gywneth Kong, Daniel Q. Huang, Jiong-Wei Wang, Mark Chan, Mayank Dalakoti,
Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals
Cheng Han Ng, Margaret LP Teng, Nicholas WS Chew, Kai En Chan, Jie Ning Yong, Jingxuan Quek, Darren Jun Hao Tan, Wen Hui Lim, Gabriel Sheng Jie Lee, Jessica Wong, Apichat Kaewdech, Daniel Q Huang, Jiongwei Wang, Mark Y Chan, Mazen Noureddin, Mohammad Shad
Expert Review of Gastroenterology & Hepatology.2022; 16(9): 895. CrossRef Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
Sun Young Kim, Subin Mun, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Sang-Heon Cho, Jin-Woo Lee
Medicine.2022; 101(37): e30527. CrossRef Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
Seogsong Jeong, Won Kim, Sang Min Park
Clinical and Molecular Hepatology.2022; 28(4): 933. CrossRef Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
Cheng Han Ng, Jieling Xiao, Nicholas W. S. Chew, Yip Han Chin, Kai En Chan, Jingxuan Quek, Wen Hui Lim, Darren Jun Hao Tan, Ryan Wai Keong Loke, Caitlyn Tan, Ansel Shao Pin Tang, Xin Lei Goh, Benjamin Nah, Nicholas Syn, Dan Yock Young, Nobuharu Tamaki, Da
Frontiers in Medicine.2022;[Epub] CrossRef CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice
Rongrong Tan, Jiayang Li, Lu Liu, Qian Wu, Lei Fan, Ningning Ma, Chuwei Yu, Henglei Lu, Xuemei Zhang, Jing Chen, Likun Gong, Jin Ren
International Journal of Molecular Sciences.2022; 23(24): 15931. CrossRef
|